You are here

Disable VAT on Taiwan

Unfortunately Sage is unable to support sales of online journal subscriptions to Taiwan customers that are not Taiwan VAT registered. We apologise for any inconvenience. For more information or to place a print journal order please contact subscriptions@sagepub.co.uk.

Therapeutic Advances in Gastroenterology

Therapeutic Advances in Gastroenterology


eISSN: 17562848 | ISSN: 17562848 | Current volume: 18 | Current issue: 1 Frequency: Yearly

Journal Highlights

 

  • Launched in 2008.
  • Gold open access journal – all articles are made freely available online immediately upon publication.
  • Rigorous peer review.
  • Listed in PubMed and indexed in Science Citation Index Expanded (SCIE), Scopus, and ProQuest.
  • A leading gold open access journal in Gastroenterology and Hepatology.
  • Over 450,000 full-text article downloads in 2022.

 

Therapeutic Advances in Gastroenterology is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of gastroenterology and hepatology. Please see the aims and scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).

This journal flipped to open access on September 1, 2017.

Diversity, Equity and Inclusion Statement

Therapeutic Advances in Gastroenterology promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the gastroenterology community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.

Submission information

Submit your manuscript today at http://mc.manuscriptcentral.com/taig.

Please see the submission guidelines tab for more information on how to submit your article to the journal.

Open access information

Unsolicited manuscripts submitted to Therapeutic Advances in Gastroenterology are subject to an article processing charge (APC) of $3,200 USD. The APC for a Plain Language Summary is $5,000 USD. These articles will be published under a Creative Commons licence and will be made openly available.

The APC is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.

Contact

Please direct any queries to alex.baliani@sagepub.co.uk.

 

Therapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in gastroenterology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.

The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.

Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable.

The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees; online publication is usually within 3 weeks of Acceptance.

Executive Editor
Alessandro Baliani SAGE Publications Ltd, UK
Associate Editors
Ray Chung Massachusetts General Hospital, Boston, MA, USA
Subrata Ghosh University College Cork, Cork, Ireland
Marietta Iacucci The University of Birmingham, Birmingham, United Kingdom
Sahil Khanna Mayo Clinic, Rochester, MN, USA
Rupert Leong University of Sydney, Sydney, Australia
Jimmy K. Limdi Northern Care Alliance NHS Foundation Trust & University of Manchester, Manchester, UK
Ren Mao The first affiliated hospital of Sun Yat-sen University, Guangzhou, China
Remo Panaccione University of Calgary, Alberta, Canada
Maitreyi Raman University of Calgary, Calgary, AB, Canada
Atsushi Sakuraba, MD, PhD Rush University Medical Center, USA
Edoardo V. Savarino University of Padua, Padua, Italy
Carmelo Scarpignato, MD, FRCP, FEBGH University of Parma, Parma, Italy
Peter J Whorwell Wythenshawe Hospital, Manchester, UK
Oesophagus Editorial Board Members
Prof. Michele Cicala, MD, PhD, AGAF Campus Bio-Medico University Hospital Foundation
Silvia Salvatore, MD, PhD Associate Professor of Pediatrics, Department of Medicine and Technological Innovation, University of Insubria, Varese Italy
Arvind J Trindade, MD, FASGE, FACG Rutgers University-New Brunswick, Robert Wood Johnson Medical School
Kee Wook Jung, MD, PhD Asan Medical Center, Seoul, Korea
Stomach Editorial Board Members
Talebi Bezmin Abadi, PhD Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Sergio Fallone de Andrade, PhD, CBIOS Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Lisboa, Portugal
Guido Granata, MD, PhD Clinical and Research Department for Infectious Diseases, National Institute for Infectious Diseases "L. Spallanzani", Rome, Italy
Christie Jeon, ScD UCLA Fielding School of Public Health, USA
Limas Kupcinskas, MD, PhD Lithuanian University of Health Sciences hospital, Lithuania
Peter Malfertheiner Otto-von-Guericke-Universitet, Magdeburg, Germany
Prof. Muhammad Miftahussurur, MD., Ph.D Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya,Indonesia
Kentaro Sugano Jichi Medical University, Tochigi-ken, Japan
Professor Mitsushige Sugimoto, MD, PhD, AGAF Division of Genome-Wide Infectious Microbiology, Research Center for GLOBAL and LOCAL Infectious Disease, Oita University, Japan
Deng-Chyang Wu Kaohsiung Medical University Hospital, Hong Kong, China, PRC, Hong Kong, China
Inflammatory Bowel Disease Editorial Board Members
Jordan Axelrad NYU Langone Health, NYU School of Medicine, New York, NY, USA
Johan Burisch, MD, PhD, DMSci Gastrounit, Copenhange University Hospital - Amager and Hvidovre, Hvidovre, Denmark
Andrea Cassinotti Gastroenterology and Digestive Endoscopy Unit, ASST Sette Laghi, Varese, Italy
Annamarie de Vries Erasmus MC University Medical Center, Rotterdam, The Netherlands
Paulo Gustavo Kotze Catholic University of Paraná (PUCPR) Curitiba, Brazil
Derek Jewell University of Oxford, Oxford, UK
Uri Kopylov Sheba Medical Center, Tel Hashomer, Israel
Torsten Kucharzik University Teaching Hospital Lüneburg, Lüneburg, Germany
MD, PhD, Prof. Christian Lodberg Hvas Aarhus University and Aarhus University Hospital, Denmark
Uma Mahadevan-Velayos University of California, San Francisco, CA, USA
Xavier Roblin University Hospital of Saint-Etienne, Saint-Etienne, France
Simone Saibeni Rho Hospital, Rho, Milan, Italy
Bo Shen, MD Columbia University Irving Medical Center, New York, NY, USA
Shinya Sugimoto, MD, PhD, FJGES Keio University School of Medicine, Tokyo, Japan
Thomas Ullman Mount Sinai Medical Center, New York, NY, USA
Gillian Watermeyer Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa
Liver Editorial Board Members
Stephen Harrison Brooke Army Medical Center, San Antonio, TX, USA
Deepak Joshi, PhD, FRCP King's College Hospital, London, UK
Daryl Lau Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Georg Lauer Massachusetts General Hospital, Boston, MA, USA
Jean-Michel Pawlotsky Henri Mondor Hospital, University of Paris, Criteil, France
Daniel Pratt Massachusetts General Hospital, Boston, MA, USA
Xingshun Qi General Hospital of Shenyang Military Area, Shenyang, China
Kenneth Sherman, MD, PhD University of Cincinnati, United States
Mark Sulkowski Johns Hopkins University School of Medicine, Baltimore, MD, USA
Pancreas Editorial Board Members
László Czakó, MD, MSc, PhD, DSc Center of Gastroenterology, Department of Medicine, University of Szeged, Szeged, Hungary
Lianghao Hu, MD, PhD Second Military Medical University, Shanghai, China
Robert C. G. Martin II, MD, PhD, FACS University of Louisville, KY, USA
Wen-Bin Zou, MD. Department of Gastroenterology, Shanghai Changhai Hospital, China
Gastrointestinal Oncology Editorial Board Members
Sujata Biswas University of Oxford, Oxford, UK
John M Carethers University of Michigan, Ann Arbor, MI, USA
Tsutomu Chiba Graduate School of Medicine, Kyoto University, Japan
Dan Chung Massachusetts General Hospital, Boston, MA, USA
Peirong Ding, MD, PhD Sun Yat-Sen University Cancer Center
Prof Anastasios Koulaouzidis MD DM PhD FEBG Pomeranian Medical University, Szczecin, Poland
Jaw-Town Lin Fu Jen Catholic University, New Taipei City, Taiwan
Reinier G.S. Meester, MSc, PhD Stanford University, USA
David Mark Pritchard Liverpool University, Liverpool, UK
Doug Taupin The Canberra Hospital, Canberra, ACT, Australia
Toshio Uraoka, MD, PhD Gunma University Graduate School of Medicine, Japan
Bertram Wiedenmann, MD Charité University Medicine Berlin, Berlin, Germany
Benjamin Wong, MBBS, MD, PhD, MRCP, FHKCP, FHKAM, FRCP, FACG University of Hong Kong, Hong Kong, China, PRC, Hong Kong, China
Neurogastroenterology and Motility Editorial Board Members
Lin Chang, MD, AGAF UCLA Division of Digestive Diseases, Los Angeles, CA, USA
Brooks D. Cash, MD, AGAF, FACG, FASGE McGovern Medical School at UTHealth Houston, USA
Kokann Gwee, MBBS, MRCP, MMed, PhD, Adjunct Associate Professor of Medicine Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Jóhan P Hreinsson, MD, PhD Sahlgrenska University Hospital, Gothenburg, Sweden
Ammar Hassanzadeh Keshteli, MD, PhD Division of Gastroenterology, Department of Medicine, University of Alberta,Canada
Brad Kuo, MD, MSc Massachusetts General Hospital, Boston, MA, USA
Edith Lahner, MD, PhD Ass Prof Gastroenterology, Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Sant’Andrea University Hospital, Gastroenterology Unit, Rome, Italy
Niranga Manjuri Devanarayana, MBBS, MD, PhD University of Kelaniya, Thalagoall Road, Ragama, Sri Lanka
Giovanni Marasco, MD, PhD Universitaria di Bologna, Bologna, Italy
Ali Rezaie, (MD, MSc) Cedars Sinai, Los Angeles, USA
Jordi Serra MD, PhD Digestive System Research Unit. University Hospital Vall d'Hebron. Barcelona. Spain
Miranda A.L. van Tilburg, PhD. University of North Carolina, University of Washington, and Cape Fear Valley Health Graduate Medical Education, USA
Nutrition Editorial Board Members
Julian A. Abrams Columbia University College of Physicians & Surgeons, New York, NY, USA
Peter Green Columbia University College of Physicians and Surgeons, New York, NY, USA
Endoscopy Editorial Board Members
Ivo Boškoski, MD, PhD, FESGE Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Luca Elli, PhD Università degli Studi di Milano, Fondazione IRCCS Ca' Granda, Italy Ospedale Maggiore Policlinico
Antonio Z Gimeno-García, MD, PhD Department of Gastroenterology, University Hospital of the Canary Islands, Spain
Osamu Goto, MD, PhD Nippon Medical School, Graduate School of Medicine, Tokyo, Japan
Martin Keuchel, MD, FESGE, FASGE, FEBGH Department for Internal Medicine, Agaplesion Bethesda Krankenhaus Bergedorf, Hamburg, Germany
Prof. Marcello Fabio Maida, MD Kore University of Enna, Italy
José Perea García, MD, PhD, MSc Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain
Neal Shahidi, MD FRCPC PhD University of British Columbia, Canada
Vishal G Shelat, MBBS, FRCSEd, FAMS, FEBS, CPHQ Tan Tock Seng Hospital, Singapore
Yoji Takeuchi, MD, FJGES Department of Endoscopy and Endoscopic Surgery, Gunma University Hospital, Japan
Naohisa Yoshida, MD, PhD Kyoto Prefectural University of Medicine, Japan
Biostatistical Editors
Jacek Bogucki Lublin Medical University, Lublin, Poland
Elisabete Carolino Lisbon Polytechnic Institute, Lisbon, Portugal
Nirav Patil Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
Milada Cvancarova Småstuen Oslo Metropolitan University, Oslo, Norway
Social Media Editor
Sheng Wei Lo The University of Melbourne, Northern Health, Melbourne, Australia
Editorial Board for Accessible Research
Sidhartha R. Sinha, MD, AGAF Stanford University School of Medicine, Stanford, USA
Aalam Sohal, MD Creighton University, Phoenix, Arizona, USA
Editorial Review Board
Ehsan Nazemalhosseini -Mojarad Leiden University Medical Center, The Netherlands
Salim Abunnaja, MD, FACS, FASMBS West Virginia University, US
Dr. Tamer A. Addissouky, PhD Menoufia University, Egypt
Ridwan Olamilekan Adesola, DVM Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, USA
Dr Shivaraj Afzalpurkar, MBBS, MD, DrNB Nanjappa Multi-speciality Hospitals, Davangere, Karnataka
Mohammad Aghaali, MD, PhD Qom University of Medical Sciences, Qom, Iran
Everson Luiz de Almeida Artifon, MD, MBA, PhD, FASGE University of Sao Paulo, Brazil
Reza Aminnejad, MD Clinical Research and Development Center, Qom University of Medical Sciences, Qom, Iran
Dmitrii Andreev, MD, PhD Russian University of Medicine, Moscow, Russia
Luca Antonioli, PhD University of Pisa, Italy
Dmitrii Atiakshin, MD RUDN University, Moscow, Russia
Nathaniel Aviv Cohen, MD Tel Aviv University, Tel Aviv, Israel
Fares Ayoub, MD Baylor College of Medicine, Houston, TX, USA
Xiaoyin Bai, MD Peking Union Medical College Hospital, China
Dr. Suranjana Banik, MD, PDF Department of Clinical Genetics, Christian Medical College, Vellore, Tamil Nadu, India
Haggai Bar-Yoseph ,MD Rambam Health Care Campus, Haifa, Israel
Federico Barbaro, MD, PhD Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
Brigida Barberio, MD, PhD Departement of Surgery, Oncology, Gastroenterology, Gastroenterology Uni, University of Padova, Padova, Italy.
Dr Alex Barnes, MD FRACP MPH PhD BE(Hons)(Mecht) BMaCompSc Flinders Medical Centre, Australia
Zsolt Barta,MD, PhD University of Debrecen, Hungary
Shouki Bazarbashi, MBBS King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Nicolas Benech ,MD, PhD Hôpital de la Croix-Rousse, France
Jurjen J. Boonstra, MD, PhD Leiden University Medical Center, The Netherlands
Dmitry S. Bordin , PhD, MD A.S. Loginov Clinical Scientific Centre, Moscow, Russia
James F. Brown, BSc, PhD, FBPhS University of Portsmouth, UK
Stefania Bundud, MD, PhD Carol Davila University of Medicine and Pharmacy, Romania
Maria Cappello, MD University of Palermo, Palermo, Italy
Manuela Cesaretti, MD, PhD San Camillo Forlanini Hospital, Rome, Italy
Felipe Chaim, MD, PhD UNICAMP, Brazil
Hideyuki Chiba, MD, PhD Omori Red Cross Hospital, Japan
Sakkarin Chirapongsathorn, MD, MSc Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand
Chiao-Hsiung Chuang ,MD National Cheng-Kung University Hosptial, Taiwan
Chong Chun-Wie, PhD School of Pharmacy, Monash University Malaysia, Malaysia
Fortunata Civitelli, MD, PhD Sapienza Università di Roma, Roma, Italy
Diego Coletta, MD, PhD IRCCS Regina Elena National Cancer Institute, Rome, Italy
Ruben Colman, MD, PhD Stanford University, Palo Alto, California, USA
Orla Craig, MD Mater Misericordiae University Hospital, Dublin, Ireland
Elton Dajti, MD Gastroenterology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Antoine Debourdeau, MD Université de Montpellier, Montpellier, France
Luc Derijks, PharmD, PhD Máxima Medical Center, Veldhoven, the Netherlands
Anjan Dhar, DM, MD, FRCPE, AGAF, PGCME, FHEA Teesside University, UK
Jernej Dolinšek, MD, PhD University Medical Center Maribor, Slovenia
David Drobne, MD, PhD University Medical Center Ljubljana, Slovenia
Audrius Dulskas ,MD, PhD, FACS National Cancer Institute, Lithuania
Tolga Düzenli, MD, PhD. Hitit University, Turkiye
Adam Fabisiak, MD, PhD Department of Digestive Tract Diseases, Medical University of Lodz, Lodz, Poland
Adam S. Faye MD, MS NYU Langone Health, NYU Grossman School of Medicine, NYC, NY, US
Linda A. Feagins, MD Dell Medical School - The University of Texas at Austin, Texas, USA
Amanda C Fifi, MD University of Miami Miller School of Medicine, USA
Stefano Fusco, MD University Hospital Tübingen, Germany
Khushboo Gala, MBBS Mayo Clinic, Rochester MN, USA
Camilla Gallo, MD Università degli Studi di Milano Bicocca, Milan, Italy
Yuan Gao, M.D. Beijing Youan hospital, Capital Medical University, Beijing, China
Giorgio Ammerata, MD ''Magna Graecia" University Hospital, Catanzaro, Italy
Rimma Goldberg, MBBS, BMedSc, FRACP, PhD Monash University, Australia
Milli Gupta, MD, FRCPC University of Calgary Cumming School of Medicine. Calgary, Canada
Tae-Geun Gweon, MD, PhD Bucheon St. Mary's Hospital, The Catholic University of Korea, College of Medicine, Seoul, South Korea
Claire Han, PhD, DNP, RN, ARNP The Ohio State University James Comprehensive Cancer Center, Columbus, OH, USA
Dr Sailish Honap, MBChB (Hons), MRes, MRCP (UK) St George’s University Hospitals NHS Foundation Trust, London, UK
Isabel Hujoel, MD University of Washington, USA
Ryoji Ichijima, MD, PhD Saiseikai Kawaguchi General Hospital, Kawaguchi, Saitama, Japan
Masahiro Itonaga, M.D., Ph.D. Wakayama Medical University, Wakayama, Japan
Mateusz Jagielski, MD, PhD Nicolaus Copernicus University in Torun, Poland
Deepanshu Jain, MD Center for Interventional Endoscopy, AdventHealth, USA
Sung Ill Jang, MD, PhD Gangnam Severance Hospital, Yonsei University College of Medicine, South Korea
Salmaan Jawaid, MD Baylor College of Medicine, TX. USA
Willem Johannes ,MD,PhD Erasmus MC, Rotterdam, The Netherlands
Amrit K. Kamboj, MD Cedars-Sinai Medical Center, Los Angeles, CA, USA
Christian Karime, MD Mayo Clinic, Jacksonville, Florida, United States
Dr David KARSENTI, MD Clinique Paris-Bercy, France
Tawfik Khoury, MD Galilee Medical Center, Nahariya, Israel
Yoshiyasu Kono Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan
Suneeta Krishnareddy, MD, MS Columbia University Irving Medical Center, USA
Zsuzsanna Kürti, MD, PhD Javorszky Odon Hospital, Vac, Hungary, Europe
Marco Lanzillotta ,MD, PhD San Raffaele Scientific Institute, Italy
Zhihai Liang, MD The First Affiliated Hospital OF Guangxi Medical University, Guangxi, China
Zhuan Liao, MD Changhai Hospital, China
Maria A. LIVZAN, MD Department of Faculty Therapy and Gastroenterology, Rector of Omsk Medical University Omsk, Russia
Timur Liwinski, MD University Psychiatric Clinics Basel, Switzerland
Gaochen Lu, MD Nanjing Medical University, Second Affiliated Hospital, Jiangsu, China
Lisa Lungaro, PhD Arcispedale Sant'Anna Azienda Ospedaliero-Universitaria di Ferrara, Italy
Dakui Luo, PhD Fudan University Shanghai Cancer Center, Shanghai, China
Mihai Mara Madalina, MD, PhD “Elias” Emergency University Hospita, Bucharest, Romania
Marco Manfredi, MD, PhD Chief of Pediatrics at Azienda USL-IRCCS di Reggio Emilia, Italy
Alberto Maringhini, MD Azienda di Rilievo Nazionale ed Alta Specializzazione (QRNAS) Civico e Benfratelli, Palermo, Italy
Dr. Srujitha Marupuru, PhD, MS, PharmD Department of Pharmacy Practice, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, USA
Sara Massironi, MD, PhD Vita-Salute San Raffaele University, Milan, Italy
Paul Middleton MBChB (Hons), MRCP, BSc (Hons) Institute of Clinical Sciences, Imperial College London, UK
Edina Molnár, PhD Department of Psychology, University of Debrecen, Debrecen, Hungary
Alessandro Mussetto, MD Unit of Gastroenterology, Santa Maria delle Croci Hospital, Ravenna - Italy
Konosuke Nakaji, MD, FACP Endoscopy Center, Aishinkai Nakae Hospital, Wakayamashi, Wakayama, Japan
Lukasz Nawacki, PhD The Jan Kochanowski University in Kielce, Poland
Sidra Naz, MD The University of Texas MD Anderson Cancer Center Houston, USA
Judy Nee, MD Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
Fredy Nehme, MD, MS Department of Gastroenterology and Hepatology, Indiana University School of Medicine, Indiana, USA
Leila Neshatian, MD, MSc, AGAF Stanford University School of Medicine, Palo Alto, California, USA
Qin Xiang Ng, MBBS, MPH National University of Singapore, Singapore
Nurulamin Noor, PhD, MRCP University of Cambridge, UK
Klementina Ocskay, MD, PhD Heim Pál National Pediatric Institute, Budapest, Hungary
Kenichiro Okimoto, MD, PhD, FJGES Chiba University Hospital, Japan
Olga Maria Nardone, MD, PhD University Federico II of Naples, Naples, Italy
Daniéla Oliveira Magro, PhD State University of Campinas UNICAMP SP, Brazil
Partha Pal, MD, DNB, MRCP (UK), GASGE Asian Institute of Gastroenterology, Hyderabad, India
Vilas Patwardhan, MD Beth Israel Deaconess Medical Center, Boston, MA, USA
Dániel Pécsi, MD, PhD University of Pécs, Pécs, Hungary
Simone Peters, PhD Monash University Alfred Health, Melbourne, Australia
Sailaja Pisipati, MD, FRCS Division of Digestive Diseases at Emory University, Atlanta, Georgia, USA
Adonis Protopapas, MD, MSc. AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
Mitchell L Ramsey, MD The Ohio State University Wexner Medical Center, Ohio, US
Yanqiao Ren, MD, PhD Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Joana Revés, MD Department of Gastroenterology, Hospital Beatriz Ângelo, Loures, Portugal
Maria Rogalidou, MD, PhD University of Athens, Agia Sofia Children's Hospital, Athens, Greece
Yasin Sahin, MD Pediatric Gastroenterology Department of Gaziantep Science and Technology University and Dr. Ersin Arslan Training and Research Hospital, Gaziantep, Turkey
Mafalda Santiago, PhD CINTESIS RISE, University of Porto, Porto, Portugal
Keisaku Sato, PhD Indiana University School of Medicine, USA
Shintaro Sagami, MD, PhD Kitasato University Kitasato Institute Hospital, Japan
Anupam Kumar Singh, MD, DM Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Arshdeep Singh, MD, DM Dayanand Medical College and Hospital, Punjab, India
Heithem SOLIMAN, MD, PhD Hospital Louis Mourier, Université de Paris - Cité, France
Ashish Srinivasan,MBBS (Hon I), Ph.D, FRACP Austin Health, Melbourne Australia
Jiangwei Sun, PhD Karolinska Institute, Sweden
Prateek Suresh Harne, MD University of Texas Health Science Center and McGovern Medical School, Houston, TX
Gaurav Syal, MD, MHDS University of California San Diego, La Jolla, CA, USA
Juha Taavela, MD, PhD Tampere University Hospital, Finland
Tae-Geun Gweon, MD, PhD Bucheon St. Mary's Hospital, The Catholic University of Korea, Republic of Korea
Ahmed Tawheed, MD Helwan University, Cairo, Egypt
Andrea Tenca, MD, PhD Helsinki University and Helsinki University Hospital HUS, Helsinki, Finland
Amelie Therrien, MD, Msc Celiac Center, Beth Israel Deaconess Medical Center, MA, USA
Cristian George Tieranu, M.D., Ph.D. Department of Gastroenterology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
Avinash Tiwari, MD, DM Regency Hospital, Kanpur, India
Koichi Tomita , MD, PhD The University of Texas MD Anderson Cancer Center, Houston, Texas
Adina Turcu-Stiolica, PhD. Habil. University of Medicine and Pharmacy of Craiova, Romania
Francesco Valitutti, PhD University of Perugia, Italy
Daniel Vasile Balaban, MD, PhD University of Medicine and Pharmacy Carol Davila Bucharest, Romania
Shang-Yu Wang, MD Chang Gung Memorial Hospital, Taiwan
yen-po Wang Taipei Veterans General Hospital, Taipei, Taiwan
Takuya Watanabe, MD, PhD Watanabe Internal Medicine Aoyama Clinic, Japan
Jean Winter, PhD Bowel Health Service, Flinders University, Bedford Park, South Australia, Australia
Karen Wong , MD, FRCPC University of Alberta, Canada.
Christina Wood-Wentz, MS Mayo Clinic, Rochester, MN, USA
Xianzong Ma, MMSc The Seventh Medical Center of Chinese PLA General Hospital, Beijing, China.
Hailun Xie, MD, PhD  
Seung Yeop Oh, MD, PhD Ajou University, Korea
Huichuan Yu, MD, PhD The Sixth Affiliated Hospital of Sun Yat-sen University, China
Jessica Yu, MD, MS Oregon Health and Science University, Oregon, USA
Clara YZET, MD student, PhD Amiens university Hospital, Amiens, France
Da-Wu Zeng, MD The First Affiliated Hospital, Fujian Medical University, Fuzhou, China
Zishao Zhong, MD & PhD Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China
Qingtian Zhu ,PhD Yangzhou University, China
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • Directory of Open Access Journals (DOAJ)
  • ProQuest
  • PubMed: PubMed Central (PMC)
  • Scopus
    1. Open Access
    2. Article processing charge (APC)
    3. Article Types
    4. Editorial policies
      4.1 Peer Review Policy
      4.2 Authorship
      4.3 Acknowledgements
      4.4 Funding
      4.5 Declaration of conflicting interests
      4.6 Research ethics and patient consent
      4.7 Clinical Trials
      4.8 Reporting guidelines
      4.9 Data
    5. Publishing policies
      5.1 Publication ethics
      5.2 Contributor's publishing agreement
    6. Preparing your manuscript
      6.1 Word processing formats
      6.2 Artwork, figures and other graphics
      6.3 Supplementary material
      6.4 Reference style
      6.5 English language editing services
    7. Submitting your manuscript
      7.1 ORCID
      7.2 Information required for completing your submission
      7.3 Corresponding author contact details
      7.4 Permissions
    8. On acceptance and publication
      8.1 SAGE Production
      8.2 Continuous publication
      8.3 Promoting your article
    9. Further information

    This Journal is a member of the Committee on Publication Ethics

    This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

    Please read the guidelines below then visit the Journal’s submission site http://mc.manuscriptcentral.com/taig to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

    Only manuscripts of sufficient quality that meet the aims and scope of Therapeutic Advances in Gastroenterology will be reviewed.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

     

    1. Open Access

    Therapeutic Advances in Gastroenterology is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.

    For general information on open access at SAGE please visit the Open Access page or view our Open Access FAQs.

    Back to top

    2. Article processing charge (APC)

    Unsolicited manuscripts submitted to Therapeutic Advances in Gastroenterology are subject to an article fee of 2,000 USD/1,335 GBP (+VAT where applicable*) payable upon acceptance. These articles will be published under a Creative Commons Licence and will be made openly available.

    *If the paying party is based in the European Union, to comply with European law, value added tax (VAT) must be added to the APC. Providing a VAT registration number will allow an institution to be exempt from paying this tax, except for UK institutions.

    Back to top

    3. Article types

    • Original Articles - the Editors will consider preclinical, interventional and observational studies with clearly stated aims, well-reported methodology (including main outcome measures) and results, and a discussion of the results in the context of the published literature.
    • Review Articles - these manuscripts are usually commissioned by the Editors, but the following types of high-quality review will be considered:
    • General reviews - reviews that provide a synthesis of an area that fits within the aims and scope of the journal;
    • Perspective reviews – review articles that address important new areas of general interest and afford the author the opportunity to present a forward-looking perspective on the topic;
    • Drug reviews – review articles focusing on the available evidence for the use of a particular drug or combination therapy.
    • Systematic Reviews – these should answer a specific research question and be reported according to the PRISMA guidelines. They should also include a PRISMA flow chart as a cited figure and a completed PRISMA checklist as a supplementary file (please see section 2.8).
    • Meta-analyses – these should answer a specific research question and be reported according to the PRISMA guidelines. They should also include a PRISMA flow chart as a cited figure and a completed PRISMA checklist as a supplementary file (please see section 2.8).
    • Case Reports – these structured reports should describe an unusual case and include a full review of the pertinent literature and a section on implications for clinical care.
    • Case Series– these descriptive structured reports (which do not involve formal hypotheses or pre-specified methodology or analyses) of a small group of patients should include a full review of the pertinent literature and a section on implications for clinical care.
    • Study Protocols– these can be for forthcoming or ongoing research. Information on trial registration (where applicable) and ethics approval should be included in the manuscript.
    • Letters to the Editor – these brief opinion pieces should be as concise as possible, usually no more than 1000 words.

    The journal considers the results of rigorous, well-designed studies that demonstrate “no effect” or that fail to replicate previous work (“negative data”) as important to the advancement of science. Therapeutic Advances in Gastroenterology welcomes short reports on null or negative results as long as the papers are based on strong hypothesis testing.

    Back to top

    4. Editorial policies

    4.1 Peer review policy

    The journal's policy is to obtain at least two independent reviews of each article. Therapeutic Advances in Gastroenterology operates a conventional single-blind reviewing policy in which the reviewer's name is always concealed from the submitting author.  Referees will be encouraged to provide substantive, constructive reviews that provide suggestions for improving the work and distinguish between mandatory and non-mandatory recommendations.  All manuscripts accepted for publication are subject to editing for presentation, style and grammar. Any major redrafting is agreed with the author but the Editor's decision on the text is final.

    As part of the submission process you will be asked to provide the names of 3 peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:

    • The reviewer should have no prior knowledge of your submission
    • The reviewer should not have recently collaborated with any of the authors
    • Reviewer nominees from the same institution as any of the authors are not permitted

    You will also be asked to nominate peers who you do not wish to review your manuscript (opposed reviewers).

    Please note that the Editors are not obliged to invite/reject any recommended/opposed reviewers to assess your manuscript.

    The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.

     

    4.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

    The list of authors should include all those who can legitimately claim authorship. This is all those who:

    • Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
    • Drafted the article or revised it critically for important intellectual content,
    • Approved the version to be published,
    • Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

    Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

    4.3 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

    4.3.1 Writing assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance.

    It is not necessary to disclose use of language polishing services.

    Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

    4.4 Funding

    Therapeutic Advances in Gastroenterology requires all authors to acknowledge their funding in a consistent fashion under a separate heading.  Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. 

    4.5 Declaration of conflicting interests

    It is the policy of Therapeutic Advances in Gastroenterology to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.

    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

    For guidance on conflict of interest statements, please see the ICMJE recommendations.

    4.6 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

    Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

    4.7 Clinical trials

    Therapeutic Advances in Gastroenterology endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be included at the end of the abstract.

    4.8 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

    4.9 Data

    SAGE acknowledges the importance of research data availability as an integral part of the research and verification process for academic journal articles.

    Therapeutic Advances in Gastroenterology requests all authors submitting any primary data used in their research articles alongside their article submissions to be published in the online version of the journal, or provide detailed information in their articles on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include but are not limited to statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original research. The editor may consider limited embargoes on proprietary data. The editor can also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations. For further information, please contact the editorial office at gastro@sagepub.co.uk

    Back to top

    5. Publishing policies

    5.1 Publication ethics

    SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway
     

    5.1.1 Plagiarism

    Therapeutic Advances in Gastroenterology and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

    5.1.2 Prior publication

    If material has been previously published, it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.

    5.2 Contributor's publishing agreement

    Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Therapeutic Advances in Gastroenterology publishes manuscripts under Creative Commons licenses. The standard  license for the journal is Creative Commons by Attribution Non-Commercial (CC BY-NC), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit SAGE's OA licenses page.

    Alternative license arrangements are available, for example to meet particular funder mandates, made at the author’s request.

    Back to top

    6. Preparing your manuscript

    6.1 Word processing formats

    The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

    6.2 Artwork, figures and other graphics

    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines  

    Figures supplied in color will appear in color online.

    6.3 Supplementary material

    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplementary files.

    6.4 Reference style

    Therapeutic Advances in Gastroenterology adheres to the SAGE Vancouver reference style. Please review the guidelines on SAGE Vancouver to ensure your manuscript conforms to this reference style.

    If you use EndNote or Zotero to manage references, you can download the appropriate output style file to help format your references quickly.

    EndNote: here 
    Zotero: here

    6.5 English language editing services

    Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.

    Back to top

    7. Submitting your manuscript

    Therapeutic Advances in Medical Oncology is hosted on SAGE Track, a web-based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit http://mc.manuscriptcentral.com/taig login and submit your article online.

    IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created.  For further guidance on submitting your manuscript online please visit ScholarOne Online Help.

    7.1 ORCID

    As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a persistent digital identifier that distinguishes researchers from every other researcher and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities ensuring that their work is recognised.

    We encourage all authors to add their ORCIDs to their SAGE Track accounts and include their ORCIDs as part of the submission process. If you don’t already have one you can create one here.

    7.2 Informtion required for completing your submission

    You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).

    7.3 Corresponding author contact details

    Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.

    7.4 Permissions

    Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Author Gateway

    Back to top

    8. On acceptance and publication

    If your paper is accepted for publication after peer review, you will first be asked to complete the contributor’s publishing agreement. Once your manuscript files have been sent to SAGE Production, the corresponding author will be asked to pay the article processing charge (APC) via a payment link. Once the APC has been processed, your article will be prepared for publication and can appear online within an average of 30 days. Please note that no production work will occur on your paper until the APC has been received.

    8.1 SAGE Production

    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly.  Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.

    8.2 Online publication

    One of the many benefits of publishing your research in an open access journal is the speed to publication. With no page count constraints, your article will be published online in a fully citable form with a DOI number as soon as it has completed the production process. At this time it will be completely free to view and download for all.

    8.3 Promoting your article

    Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximise your article’s impact with Kudos

    Back to top

    9. Further information

    Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Therapeutic Advances in Gastroenterology editorial office as follows:

    gastro@sagepub.co.uk

    For all commercial sales and sponsorship enquiries, including advertising, reprints and supplements, please contact:

    Commercial Sales Team, London, UK Tel: +44 20 7336 1205 Email: reprints@sagepub.co.uk

    Back to top

     

    EC Rep

    International Associates Auditing & Certification Limited
    The Black Church, St Mary's Place,
    Dublin 7, D07 P4AX Ireland
    Sage's GPSR statement